The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by FTI Consulting .

Filed returns
8
match these filters
Matching filed returns per period 0 0 1 1 2 Sep–Dec 2020: 1 filed returns May–Aug 2021: 1 filed returns Sep–Dec 2022: 1 filed returns Jan–Apr 2023: 2 filed returns Jan–Apr 2025: 1 filed returns Jan–Apr 2026: 1 filed returns May–Aug 2026: 1 filed returns 2023 2025 2026
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
May–Aug 2026 FTI Consulting Finance Mastercard introductory meetings (Public policy or programme) 4 On lobbying.ie
Jan–Apr 2026 FTI Consulting Finance Mastercard Meeting Request (Public policy or programme) 9 On lobbying.ie
Jan–Apr 2025 FTI Consulting Finance Mastercard outreach to newly appointed Ministers (Public policy or programme) 8 On lobbying.ie
Jan–Apr 2023 FTI Consulting Finance Mastercard sent an outreach email to the Taoiseach’s Chief of Staff requesting a meeting with the Taoiseach in Mastercard’s Leopardstown offices. (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2023 FTI Consulting Finance Mastercard sent an outreach email to the Taoiseach’s office requesting a meeting in Mastercard’s Leopardstown offices. (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2022 FTI Consulting Finance Mastercard met with Tánaiste Leo Varadkar’s Chief of Staff, Brian Murphy to discuss Mastercard’s operations in Ireland. (Public policy or programme) 1 On lobbying.ie
May–Aug 2021 FTI Consulting Health GW Pharmaceuticals sent a letter to An Taoiseach Micheal Martin with an offer to brief him on GW’s approach to developing regulatory approved cannabis-based medicines to patients. (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2020 FTI Consulting Health GW Pharmaceuticals sent a letter to An Taoiseach Micheal Martin to request a meeting to discuss cannabinoid science and GW Pharmaceuticals in response to issues raised in the Dáil relating to GW’s Epidyolex. (Public policy or programme) 1 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Finance 6 75.0%
Health 2 25.0%